Journal
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE
Volume 5, Issue 1, Pages 22-29Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncpcardio1066
Keywords
beta(2)-adrenoceptor; epinephrine; Gi protein; stress cardiomyopathy; Takotsubo cardiomyopathy
Categories
Funding
- Medical Research Council [G0500373] Funding Source: Medline
- MRC [G0500373] Funding Source: UKRI
Ask authors/readers for more resources
Stress cardiomyopathy, also referred to as Takotsubo cardiomyopathy, is an increasingly recognized clinical syndrome characterized by acute reversible apical ventricular dysfunction. We hypothesize that stress cardiomyopathy is a form of myocardial stunning, but with different cellular mechanisms to those seen during transient episodes of ischemia secondary to coronary stenoses. In this syndrome, we believe that high levels of circulating epinephrine trigger a switch in intracellular signal trafficking in ventricular cardiomyocytes, from G(s) protein to G(i) protein signaling via the beta(2)-adrenoceptor. Although this switch to beta(2)-adrenoceptor - G(i) protein signaling protects against the proapoptotic effects of intense activation of beta(i)-adrenoceptors, it is also negatively inotropic. This effect is greatest at the apical myocardium, in which the P-adrenoceptor density is greatest. Our hypothesis has implications for the use of drugs or devices in the treatment of patients with stress cardiomyopathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available